natgillin/translations-raw huggingface dataset:
In Cayston, aztreonam is available as a ‘lysine salt', which makes it possible for the antibiotic to be breathed directly into the lungs without causing irritation. 
Aztreonam je od osemdesetih let prejšnjega stoletja na voljo v obliki injekcije kot „argininska sol“ V zdravilu Cayston je aztreonam na voljo kot „lizinska sol“, ki omogoča, da se antibiotik vdihne neposredno v pljuča, ne da bi to povzročilo draženja.
Cayston is a powder and solvent that are made up into a nebuliser solution. 
Zdravilo Cayston je prašek in vehikel za pripravo raztopine za nebulator.
In cystic fibrosis these secretions become thick, blocking the airways and the flow of digestive juices. 
Pri cistični fibrozi ti izločki postanejo zgoščeni, kar zapira dihala in pretok prebavnih sokov.
An additional study compared four weeks of Cayston with placebo in patients with mild lung disease due to cystic fibrosis. 
V dodatni študiji so primerjali štiritedensko dajanje zdravila Cayston s placebom pri bolnikih z zmernim pljučnim obolenjem, ki je posledica cistične fibroze.
How has Cayston been studied? 
Kako je bilo zdravilo Cayston raziskano?
How does Cayston work? 
Kako zdravilo Cayston deluje?
What is Cayston used for? 
Za kaj se zdravilo Cayston uporablja?
What is Cayston? 
Kaj je zdravilo Cayston?
Cayston was more effective than placebo at suppressing lung infection caused by P. aeruginosa bacteria in patients with cystic fibrosis. 
Zdravilo Cayston je bilo pri zaviranju kronične pljučne okužbe, ki jo povzroči bakterija P. aeruginosa, pri odraslih bolnikih s cistično fibrozo učinkovitejše od placeba.
A bronchodilator (a medicine that widens the airways in the lungs) should be used before each dose of Cayston. 
Pred vsakim odmerkom zdravila Cayston je treba vzeti bronhodilator (zdravilo, ki širi dihalne poti v pljučih).
How is Cayston used? 
Kako se zdravilo Cayston uporablja?
It works by attaching to proteins on the surface of the P. aeruginosa bacteria. 
Deluje tako, da se veže na beljakovine na površini bakterije P. aeruginosa, kar bakteriji onemogoči gradnjo celičnih sten zaradi česar odmrejo.
Date of first authorisation: 4 January 2007 Date of latest renewal: 21 November 2011 
Datum prve odobritve: 4. januar 2007 Datum zadnjega podaljšanja: 21. november 2011
It contains important information reminding you how to take ADROVANCE properly. 
Ta vsebuje pomembne informacije, ki vas spomnijo, kako pravilno jemati zdravilo ADROVANCE.
Therefore, caution should be used when these medicines are taken at the same time as ADROVANCE. 
Zato je potrebna previdnost, kadar ta zdravila uporabljate istočasno kot zdravilo ADROVANCE.
Children and adolescents ADROVANCE should not be given to children and adolescents less than 18 years of age. 
Otroci in mladostniki Zdravila ADROVANCE se ne sme dajati otrokom in mladostnikom, mlajšim od 18 let.
Since it is not known how long you should take ADROVANCE, you should discuss the need to stay on this medicine with your doctor periodically to determine if ADROVANCE is still right for you. 
Ker ni znano, kako dolgo je treba jemati zdravilo ADROVANCE, se morate glede nadaljevanja zdravljenja s tem zdravilom redno posvetovati z zdravnikom, ki bo odločil, ali je zdravljenje z zdravilom ADROVANCE za vas še vedno primerno.
ADROVANCE has no or negligible direct influence on the ability to drive and use machines. 
Zdravilo ADROVANCE nima neposrednega vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
The need for continued treatment should be re-evaluated periodically based on the benefits and potential risks of ADROVANCE on an individual patient basis, particularly after 5 or more years of use. 
Potrebo po nadaljevanju zdravljenja z zdravilom ADROVANCE je treba ponovno periodično oceniti glede na koristi in tveganja za posameznega bolnika, še posebno po 5 letih ali več uporabe.
If you take more ADROVANCE than you should If you take too many tablets by mistake, drink a full glass of milk and contact your doctor immediately. 
Če ste vzeli večji odmerek zdravila ADROVANCE, kot bi smeli Če po pomoti vzamete preveč tablet, popijte poln kozarec mleka in nemudoma pokličite zdravnika.
Due to the nature of the disease process in osteoporosis, ADROVANCE is intended for long-term use. 
Zaradi narave bolezenskega procesa osteoporoze je zdravilo ADROVANCE namenjeno za dolgotrajno uporabo.
The safety and efficacy of ADROVANCE in children less than 18 years of age have not been established. 
Varnost in učinkovitost zdravila ADROVANCE pri otrocih, mlajših od 18 let, nista bili dokazani.
• Patients should not lie down for at least 30 minutes after taking ADROVANCE and until after the first food of the day. 
• Bolnik se ne sme uleči še vsaj 30 minut po zaužitju tablete ADROVANCE in dokler ne zaužije prvega dnevnega obroka hrane.
It is important to maintain good oral hygiene when being treated with ADROVANCE. 
Pomembno je, da med zdravljenjem z zdravilom ADROVANCE vzdržujete dobro ustno higieno.
What ADROVANCE is and what it is used for What you need to know before you take ADROVANCE How to take ADROVANCE Possible side effects 
Kaj je zdravilo ADROVANCE in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo ADROVANCE Kako jemati zdravilo ADROVANCE Možni neželeni učinki
ADROVANCE is only intended for use in postmenopausal women and therefore it should not be used during pregnancy or in breast-feeding women. 
Zdravilo ADROVANCE je namenjeno le ženskam po menopavzi, zato se ga ne sme uporabljati v času nosečnosti ali dojenja.
Hypocalcaemia must be corrected before initiating therapy with ADROVANCE (see section 4.3). 
Hipokalciemijo je treba korigirati pred začetkom zdravljenja z zdravilom ADROVANCE (glejte poglavje 4.3).
What you need to know before you take ADROVANCE 
Kaj morate vedeti preden boste vzeli zdravilo ADROVANCE
As well as your treatment with ADROVANCE, your doctor may suggest you make changes to your lifestyle to help your condition, such as: 
Poleg zdravljenja z zdravilom ADROVANCE vam zdravnik lahko svetuje nekaj sprememb v načinu življenja, ki pomagajo pri vaši bolezni.
ADROVANCE should not be used during pregnancy. 
Zdravila ADROVANCE se med nosečnostjo ne sme uporabljati.
• ADROVANCE should only be swallowed after getting up for the day with a full glass of water (not less than 200 ml). 
• Bolnik mora zdravilo ADROVANCE pogoltniti zjutraj, ko vstane, s polnim kozarcem vode (ne manj kot 200 ml).
An Instruction Card is included in the carton for ADROVANCE. 
V škatli zdravila ADROVANCE je priložena kartica z navodili.
• Patients should only swallow ADROVANCE whole. 
• Bolnik mora pogoltniti celo tableto ADROVANCE.
4) Do not take ADROVANCE at bedtime or before getting up for the day. 
4) Zdravila ADROVANCE ne jemljite zvečer ali preden zjutraj vstanete.
Remember, take ADROVANCE once each week on that same day for as long as your doctor prescribes it. 
Zapomnite si - zdravilo ADROVANCE je treba vzeti le enkrat na teden, vedno na isti dan v tednu, tako dolgo, kot vam ga je predpisal zdravnik.
Other medicines and ADROVANCE 
Druga zdravila in zdravilo ADROVANCE
5) If you develop difficulty or pain upon swallowing, chest pain, or new or worsening heartburn, stop taking ADROVANCE and contact your doctor. 
5) Če se pojavijo težave ali bolečine pri požiranju, bolečine v prsih, zgaga ali če se težave z zgago stopnjujejo, prenehajte jemati zdravilo ADROVANCE in se posvetujte z zdravnikom.
When you get out of bed on the day you have chosen, and before taking your first food, drink or other medicines, swallow (do not crush or chew the tablet or allow it to dissolve in your mouth) one ADROVANCE tablet with a full glass of water (not mineral water). 
Ko na izbrani dan zjutraj vstanete in še preden pojeste prvo hrano ali popijete prvo pijačo ali vzamete katero koli drugo zdravilo, pogoltnite (ne zdrobite, ne žvečite in ne raztapljajte v ustih) eno tableto ADROVANCE s polnim kozarcem vode (ne z mineralno vodo).
It is likely that calcium supplements, antacids, and some oral medicines will interfere with the absorption of ADROVANCE if taken at the same time. 
Dodatki kalcija, antacidi in nekatera zdravila, ki jih zaužijete, lahko motijo absorpcijo zdravila ADROVANCE, če jih vzamete istočasno.
Patients should be instructed that if they miss a dose of ADROVANCE they should take one tablet on the morning after they remember. 
Bolnikom je treba naročiti, naj v primeru, da pozabijo vzeti odmerek zdravila ADROVANCE, vzamejo eno tableto zjutraj potem, ko se spomnijo.
ADROVANCE must be taken with water only (not mineral water) at least 30 minutes before the first food, beverage, or medicinal product (including antacids, calcium supplements and vitamins) of the day. 
Zdravilo ADROVANCE je treba vzeti izključno z navadno vodo (ne z mineralno vodo) najmanj 30 minut pred prvim dnevnim obrokom hrane in pijače ali zaužitjem drugih zdravil (vključno z antacidi, pripravki kalcija in vitamini).
Take one ADROVANCE tablet once a week. 
Vzemite eno tableto ADROVANCE enkrat na teden.
6) After swallowing your ADROVANCE tablet, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins. 
6) Ko pogoltnete tableto ADROVANCE, vsaj še 30 minut počakajte, preden zaužijete prvo hrano, pijačo ali katero koli drugo zdravilo, vključno z antacidi, dodatki kalcija in vitamini.
5 How to store ADROVANCE Contents of the pack and other information 
Shranjevanje zdravila ADROVANCE Vsebina pakiranja in dodatne informacije
• if you are allergic to alendronic acid, colecalciferol or any of the other ingredients of this medicine (listed in section 6), 
• če ste alergični na alendronsko kislino, holekalciferol ali katero koli sestavino tega zdravila
You may be advised to have a dental check-up before starting treatment with ADROVANCE. 
Zdravnik vam bo lahko pred začetkom zdravljenja z zdravilom ADROVANCE svetoval zobozdravniški pregled.
Patients may experience certain adverse reactions (for example blurred vision, dizziness and severe bone muscle or joint pain (see section 4.8)) that may influence the ability to drive and use machines. 
Pri bolnikih se lahko pojavijo določeni neželeni učinki (npr. zamegljen vid, omotica in hude bolečine v kosteh, mišicah ali sklepih (glejte poglavje 4.8)), ki lahko vplivajo na sposobnost vožnje in upravljanja strojev.
Do not take ADROVANCE 
Ne jemljite zdravila ADROVANCE
If you forget to take ADROVANCE 
Če ste pozabili vzeti zdravilo ADROVANCE
What ADROVANCE looks like and contents of the pack 
Izgled zdravila ADROVANCE in vsebina pakiranja
What ADROVANCE is and what it is used for 
Kaj je zdravilo ADROVANCE in za kaj ga uporabljamo
If you miss a dose, take only one ADROVANCE tablet on the morning after you remember. 
Če pozabite vzeti odmerek, vzemite le eno tableto ADROVANCE naslednje jutro, potem ko se spomnite.
Irritation, inflammation or ulceration of the gullet (oesophagus - the tube that connects your mouth with your stomach) often with symptoms of chest pain, heartburn, or difficulty or pain upon swallowing may occur, especially if patients do not drink a full glass of water and/or if they lie down less than 30 minutes after taking ADROVANCE. 
Po zaužitju lahko pride do draženja, vnetja ali razjede požiralnika, pogosto z bolečino v prsnem košu, zgago ali oteženim ali bolečim požiranjem, še posebej, če bolnik ne spije polnega kozarca vode in/ali če se uleže prej kot v 30 minutah po zaužitju zdravila ADROVANCE.
What is ADROVANCE used for? 
Za kaj uporabljamo zdravilo ADROVANCE?
The mean half-life of vitamin D3 in the serum following an oral dose of ADROVANCE (70 mg/2,800 IU) is approximately 24 hours. 
Povprečni razpolovni čas vitamina D3 v serumu po peroralnem odmerku zdravila ADROVANCE (70 mg/2.800 i.e.) je približno 24 ur.
ADROVANCE is effective only if taken when your stomach is empty. 
Zdravilo ADROVANCE je učinkovito samo, če ga vzamete na tešče.
ADROVANCE is not recommended for patients with renal impairment where creatinine clearance is less than 35 ml/min, due to lack of experience. 
Bolnikom z okvaro ledvic, pri katerih je kreatininski očistek manjši od 35 ml/min, zdravila ADROVANCE zaradi pomanjkanja izkušenj ne priporočamo.
ADROVANCE is a tablet containing the two active substances, alendronic acid (commonly called alendronate) and colecalciferol known as vitamin D3. 
ADROVANCE je tableta, ki vsebuje dve učinkovini: alendronsko kislino (splošno poimenovano alendronat) in holekalciferol oziroma vitamin D3.
ADROVANCE should not be used during breast-feeding. 
Zdravila ADROVANCE se med dojenjem ne sme uporabljati.
ADROVANCE is only intended for use in postmenopausal women. 
Zdravilo ADROVANCE je namenjeno le ženskam po menopavzi.
How to take ADROVANCE tablets 
Kako jemati tablete ADROVANCE
ADROVANCE is not recommended for patients with renal impairment where creatinine clearance is less than 35 ml/min (see section 4.2). 
Bolnikom, pri katerih je kreatininski očistek manjši od 35 ml/min, zdravila ADROVANCE ne priporočamo (glejte poglavje 4.2).
Patients received the lower strength (70 mg/2,800 IU) of ADROVANCE (n=350) or FOSAMAX (alendronate) 70 mg (n=332) once a week; additional vitamin D supplements were prohibited. 
Bolnice so enkrat tedensko dobivale manjšo jakost (70 mg/2.800 i.e.) zdravila ADROVANCE (n = 350) ali zdravilo FOSAMAX (alendronat) 70 mg (n = 332); jemanje dodatkov vitamina D je bilo prepovedano.
ADROVANCE studies 
Študije z zdravilom ADROVANCE
The bioavailability of the 5,600 IU vitamin D3 in ADROVANCE is similar to 5,600 IU vitamin D3 administered alone. 
Biološka uporabnost 5.600 i.e. vitamina D3 v zdravilu ADROVANCE je podobna kot pri zaužitju 5.600 i.e. vitamina D3 samega.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. 
Zdravilo ADROVANCE vsebuje laktozo in saharozo Če vam je zdravnik povedal, da ne prenašate nekaterih sladkorjev, se pred jemanjem tega zdravila pogovorite z zdravnikom.
The effect of the lower dose of ADROVANCE (alendronate 70 mg/vitamin D3 2,800 IU) plus an additional 2,800 IU Vitamin D3 for a total of 5,600 IU (the amount of vitamin D3 in the higher dose of ADROVANCE) once weekly was demonstrated in a 24-week, extension study that enrolled 619 osteoporotic post-menopausal women. 
Vpliv manjšega odmerka zdravila ADROVANCE (alendronat 70 mg/vitamin D3 2.800 i.e.) in dodatnih 2.800 i.e. vitamina D3, kar pomeni skupaj 5.600 i.e. (količina vitamina D3 v večjem odmerku zdravila ADROVANCE), enkrat tedensko, so ugotavljali v 24-tedenski podaljšani študiji, v katero je bilo vključenih 619 žensk s pomenopavzalno osteoporozo.
The bioavailability of the 2,800 IU vitamin D3 in ADROVANCE is similar to 2,800 IU vitamin D3 administered alone. 
Biološka uporabnost 2.800 i.e. vitamina D3 v zdravilu ADROVANCE je podobna kot pri zaužitju 2.800 i.e. vitamina D3 samega.
In case of overdose with ADROVANCE, milk or antacids should be given to bind alendronate. 
Če bolnik vzame prekomeren odmerek zdravila ADROVANCE, naj pije mleko ali vzame antacid, ki vežeta alendronat.
In this study, mean 25-hydroxyvitamin D levels in patients with vitamin D insufficiency at baseline (25-hydroxyvitamin D, 22.5 to 37.5 nmol/l [9 to < 15 ng/ml]) increased from 30 nmol/l (12.1 ng/ml) to 40 nmol/l (15.9 ng/ml) at week 15 in the ADROVANCE (70 mg/2,800 IU) group (n=75) and decreased from 30 nmol/l (12.0 ng/ml) at baseline to 26 nmol/l (10.4 ng/ml) at week 15 in the alendronate-only group (n=70). 
V tej študiji so se povprečne vrednosti 25-hidroksivitamina D pri bolnicah s pomanjkanjem vitamina D na začetku študije (25-hidroksivitamin D, 22,5 do 37,5 nmol/l [9 do <15 ng/ml]) v skupini, ki je prejemala zdravilo ADROVANCE (70 mg/2.800 i.e.) (n = 75), v 15. tednu zvišale s 30 nmol/l (12,1 ng/ml) na 40 nmol/l (15,9 ng/ml), v skupini, ki je prejemala le alendronat (n = 70) pa v 15. tednu znižale s 30 nmol/l (12,0 ng/ml) na 26 nmol/l (10,4 ng/ml).
The effect of the lower dose of ADROVANCE (alendronate 70 mg/vitamin D3 2,800 IU) on vitamin D status was demonstrated in a 15-week, multinational study that enrolled 682 osteoporotic postmenopausal women (serum 25-hydroxyvitamin D at baseline: mean, 56 nmol/l [22.3 ng/ml]; range, 22.5-225 nmol/l [9-90 ng/ml]). 
Vpliv manjšega odmerka zdravila ADROVANCE (alendronat 70 mg/vitamin D3 2.800 i.e.) na status vitamina D so ugotavljali v 15-tedenski, mednarodni študiji, v katero je bilo vključenih 682 žensk s pomenopavzalno osteoporozo (serumski 25-hidroksivitamin D ob začetku študije: povprečna vrednost 56 nmol/l [22,3 ng/ml]; obseg vrednosti 22,5-225 nmol/l [9-90 ng/ml]).
Talk to your doctor or pharmacist before taking ADROVANCE if: 
Pred začetkom jemanja zdravila ADROVANCE se posvetujte z zdravnikom ali farmacevtom:
It is likely that certain medicines or food additives may prevent the vitamin D in ADROVANCE from getting into your body, including artificial fat substitutes, mineral oils, the weight loss medicine, orlistat, and the cholesterol-lowering medicines, cholestyramine and colestipol. 
Določena zdravila ali dodatki hrani, vključno z umetnimi nadomestki maščob, mineralnimi olji, zdravili za hujšanje, orlistatom in zdravili za zniževanje holesterola, holestiraminom in holestipolom, lahko preprečijo absorpcijo vitamina D iz zdravila ADROVANCE v telo.
It is likely that food and beverages (including mineral water) will make ADROVANCE less effective if taken at the same time. 
Zdravilo ADROVANCE skupaj s hrano in pijačo Hrana in pijače (vključno z mineralno vodo) lahko ob sočasnem zaužitju zmanjšajo učinek zdravila ADROVANCE.
The alendronate component in the ADROVANCE (70 mg/2,800 IU) combination tablet and the ADROVANCE (70 mg/5,600 IU) combination tablet is bioequivalent to the alendronate 70 mg tablet. 
Alendronat v kombinirani tableti ADROVANCE (70 mg/2.800 i.e.) in kombinirani tableti ADROVANCE (70 mg/5.600 i.e.) je bioekvivalenten alendronatu v 70 mg tableti.
EU/1/06/364/004 - 12 tablets 
EU/1/06/364/008 - 12 tablet
The equivalence of intake of 5,600 IU of vitamin D3 weekly in ADROVANCE to daily dosing of vitamin D 800 IU has not been studied. 
Ekvivalentnost vnosa 5.600 i.e. vitamina D3 tedensko z zdravilom ADROVANCE in 800 i.e. vitamina D pri dnevnemu odmerjanju ni bila preučevana.
In healthy adult subjects (males and females), following administration of ADROVANCE 70 mg/5,600 IU after an overnight fast and two hours before a meal, the mean area under the serumconcentration-time curve (AUC0-80 hrs) for vitamin D3 (unadjusted for endogenous vitamin D3 levels) was 490.2 ng•hr/ml. 
Pri zdravih odraslih preiskovancih (moških in ženskah) je po zaužitju ADROVANCE 70 mg/5.600 i.e. tablet zjutraj na tešče in dve uri pred obrokom povprečna površina pod krivuljo serumska koncentracija-čas (AUC0-80 ur) za vitamin D3 (neprilagojen endogenim vrednostim vitamina D3) znašala 490,2 ngh/ml.
There have been side effects (for example blurred vision, dizziness and severe bone, muscle or joint pain) reported with ADROVANCE that may affect your ability to drive or operate machinery (see section 4). 
Vpliv na sposobnost upravljanja vozil in strojev Pri uporabi zdravila ADROVANCE so poročali o neželenih učinkih (na primer zamegljenem vidu, omotici in hudih bolečinah v kosteh, mišicah ali sklepih), ki lahko vplivajo na vašo sposobnost vožnje ali upravljanja strojev (glejte poglavje 4).
The equivalence of intake of 2,800 IU of vitamin D3 weekly in ADROVANCE to daily dosing of vitamin D 400 IU has not been studied. 
Ekvivalentnost vnosa 2.800 i.e. vitamina D3 tedensko z zdravilom ADROVANCE in 400 i.e. vitamina D pri dnevnemu odmerjanju ni bila preučevana.
In healthy adult subjects (males and females), following administration of ADROVANCE 70 mg/2,800 IU tablets after an overnight fast and two hours before a meal, the mean area under the serum-concentration-time curve (AUC0-120 hrs) for vitamin D3 (unadjusted for endogenous vitamin D3 levels) was 296.4 ng•hr/ml. 
Pri zdravih odraslih preiskovancih (moških in ženskah) je po zaužitju ADROVANCE 70 mg/2.800 i.e. tablet zjutraj na tešče in dve uri pred obrokom povprečna površina pod krivuljo serumska koncentracija-čas (AUC0-120 ur) za vitamin D3 (neprilagojen endogenim vrednostim vitamina D3) znašala 296,4 ngh/ml.
After 15 weeks of treatment, the mean serum 25-hydroxyvitamin D levels were significantly higher (26 %) in the ADROVANCE (70 mg/2,800 IU) group (56 nmol/l [23 ng/ml]) than in the alendronate-only group (46 nmol/l [18.2 ng/ml]). 
Po 15 tednih zdravljenja so bile povprečne vrednosti 25-hidroksivitamina D v serumu v skupini, ki je dobivala zdravilo ADROVANCE (70 mg/2.800 i.e.), pomembno višje (26 %) (56 nmol/l [23 ng/ml]) kot v skupini, ki je jemala samo alendronat (46 nmol/l [18,2 ng/ml]).
ADROVANCE is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D insufficiency. 
Zdravilo ADROVANCE je indicirano za zdravljenje pomenopavzalne osteoporoze pri ženskah s tveganjem za pomanjkanje vitamina D. Zdravilo zmanjša tveganje za vertebralne zlome in za zlome kolka.
Merck Sharp & Dohme BV Tel: +31 (0)800 99 99 000 (+31 (0)23 5153153) medicalinfo.nl@merck.com 
Merck Sharp & Dohme BV Tel: +31 (0)800 99 99 000 (+31 (0)23
EU/1/06/364/001 (2 tablets) EU/1/06/364/002 (4 tablets) EU/1/06/364/003 (6 tablets) EU/1/06/364/004 (12 tablets) 
EU/1/06/364/001 (2 tableti) EU/1/06/364/002 (4 tablete) EU/1/06/364/003 (6 tablet) EU/1/06/364/004 (12 tablet)
It is important that you take ADROVANCE for as long as your doctor prescribes the medicine. 
Če ste prenehali jemati zdravilo ADROVANCE Pomembno je, da zdravilo ADROVANCE jemljete tako dolgo, kot vam je predpisal zdravnik.
Your doctor has prescribed ADROVANCE to treat your osteoporosis and because you are at risk of vitamin D insufficiency. 
Zdravnik vam je predpisal zdravilo ADROVANCE za zdravljenje osteoporoze in zato, ker pri vas obstaja tveganje za pomanjkanje vitamina D. Zdravilo zmanjša tveganje za zlome hrbtenice in za zlome kolka pri ženskah po menopavzi.
ADROVANCE 70 mg/2,800 IU tablets 
ADROVANCE 70 mg/2.800 i.e. tablete
ADROVANCE 70 mg/2,800 IU tablets are available in packs containing 2, 4, 6 or 12 tablets. 
ADROVANCE 70 mg/2.800 i.e tablete so na voljo v pakiranjih, ki vsebujejo 2, 4, 6 ali 12 tablet.
EU/1/06/364/006 (2 tablets) EU/1/06/364/007 (4 tablets) EU/1/06/364/008 (12 tablets) 
EU/1/06/364/006 (2 tableti) EU/1/06/364/007 (4 tablete) EU/1/06/364/008 (12 tablet)
ADROVANCE 70 mg/5,600 IU tablets 
ADROVANCE 70 mg/5.600 i.e. tablete
The percentage of patients with vitamin D deficiency (serum 25-hydroxyvitamin D  22.5 nmol/l [ 9 ng/ml]) was significantly reduced by 92 % with ADROVANCE (70 mg/2,800 IU) vs. alendronate-only (1 % vs 13 %, respectively). 
Delež bolnic s pomanjkanjem vitamina D (serumski 25-hidroksivitamin D < 22,5 nmol/l [<9 ng/ml]) je bil v skupini, ki je prejemala zdravilo ADROVANCE (70 mg/2.800 i.e.), pomembno nižji (za 92 %) kot v skupini, ki je prejemala le alendronat (1 % oz. 13 %).
ADROVANCE 70 mg/2,800 IU tablets ADROVANCE 70 mg/5,600 IU tablets 
ADROVANCE 70 mg/2.800 i.e. tablete ADROVANCE 70 mg/5.600 i.e. tablete
ADROVANCE 70 mg/5,600 IU tablets are available in packs containing 2, 4 or 12 tablets. 
ADROVANCE 70 mg/5.600 i.e tablete so na voljo v pakiranjih, ki vsebujejo 2, 4 ali 12 tablet.
• ADROVANCE should not be taken at bedtime or before arising for the day. 
• Bolnik zdravila ADROVANCE ne sme vzeti pred spanjem ali preden zjutraj vstane.
Olestra, mineral oils, orlistat, and bile acid sequestrants (e.g. cholestyramine, colestipol) may impair the absorption of vitamin D. 
Olestra, mineralna olja, orlistat in izmenjevalci žolčnih kislin (npr. holestiramin, holestipol) lahko motijo absorpcijo vitamina D. Antikonvulzivi, cimetidin in tiazidi lahko povečajo razgradnjo vitamina D. Pri posameznih bolnikih lahko pride v poštev še dodatno jemanje vitamina D.
How to take ADROVANCE 
Kako jemati zdravilo ADROVANCE